Skip to main content
Clinical Trials/CTRI/2021/07/034577
CTRI/2021/07/034577
Recruiting
未知

To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema -A Prospective Randomized Controlled Trial.

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K729- Hepatic failure, unspecified
Sponsor
Institute of Liver and Biliary Sciences
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with acute liver failure defined patients with jaundice which is complicated by encephalopathy and coagulopathy within 4 weeks of the onset of jaundice and without underlying chronic liver disease with documented cerebral edema on CT\-scan and arterial ammonia \>150 ug/dL.

Exclusion Criteria

  • 1\.Age \<18 or \> 70 years
  • 2\.Hepatocellular Carcinoma
  • 3\.Active untreated Sepsis/DIC
  • 4\.Hemodynamic instability requiring high dose of vasopressors
  • 5\.Post\-resection and malignancy related liver failure
  • 6\.Coma of non\-hepatic origin
  • 7\.Patients with post renal obstructive AKI, AKI suspected due to glomerulonephritis, interstitial nephritis or vasculitis based on clinical history and urine analysis
  • 8\.Patients already meeting emergency criteria for immediate initiation of dialysis at the time of randomization (serum potassium \>6 meq/lt, metabolic acidosis ph \<7\.12, acute pulmonary edema, severe volume overload with hypoxemia non\-responsive to diuretic treatment)
  • 9\.Patients transferred from other hospitals who have already been on hemodialysis before their arrival in the intensive care unit
  • 10\.Extremely moribund patients with an expected life expectancy of less than 24 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials